<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">(.) </span>
   <span class="font26">migraine </span>
   <span class="font25">topiramate </span>
   <span class="font20">placebo </span>
   <span class="font18">headache </span>
   <span class="font17">included </span>
   <span class="font17">trials </span>
   <span class="font17">patients </span>
   <span class="font16">Headache </span>
   <span class="font16">meta-analysis </span>
   <span class="font15">prevention </span>
   <span class="font15">trial </span>
   <span class="font15">{border-style </span>
   <span class="font14">pediatric </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">Topiramate </span>
   <span class="font14">data </span>
   <span class="font14">years </span>
   <span class="font14">children </span>
   <span class="font14">days </span>
   <span class="font14">treatment </span>
   <span class="font13">effects </span>
   <span class="font13">events </span>
   <span class="font13">adverse </span>
   <span class="font13">group </span>
   <span class="font13">used </span>
   <span class="font13">PedMIDAS </span>
   <span class="font13">mean </span>
   <span class="font13">reduction </span>
   <span class="font13">study </span>
   <span class="font13">number </span>
   <span class="font13">significant </span>
   <span class="font12">-day </span>
   <span class="font12">bias </span>
   <span class="font12">outcome </span>
   <span class="font12">period </span>
   <span class="font12">studies </span>
   <span class="font12">Fig. </span>
   <span class="font12">adults </span>
   <span class="font12">clinical </span>
   <span class="font12">criteria </span>
   <span class="font12">frequency </span>
   <span class="font12">pain </span>
   <span class="font12">reported </span>
   <span class="font12">./j.-...x </span>
   <span class="font12">International </span>
   <span class="font12">Pain </span>
   <span class="font12">adolescents </span>
   <span class="font12">age </span>
   <span class="font12">baseline </span>
   <span class="font12">mg/d </span>
   <span class="font12">performed </span>
   <span class="font12">px; </span>
   <span class="font12">response </span>
   <span class="font12">{font-family </span>
   <span class="font11">./s--- </span>
   <span class="font11">Cochrane </span>
   <span class="font11">RCTs </span>
   <span class="font11">font-size </span>
   <span class="font11">relative </span>
   <span class="font11">using </span>
   <span class="font11">versus </span>
   <span class="font11">-week: </span>
   <span class="font11">Cephalalgia </span>
   <span class="font11">Placebo </span>
   <span class="font11">Table </span>
   <span class="font11">age. </span>
   <span class="font11">approved </span>
   <span class="font11">attacks </span>
   <span class="font11">cognitive </span>
   <span class="font11">controlled </span>
   <span class="font11">diagnostic </span>
   <span class="font11">double; </span>
   <span class="font11">efficacy </span>
   <span class="font11">infection, </span>
   <span class="font11">investigators </span>
   <span class="font11">migraines </span>
   <span class="font11">outcomes </span>
   <span class="font11">participants </span>
   <span class="font11">population </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">publication </span>
   <span class="font11">randomized </span>
   <span class="font11">respiratory </span>
   <span class="font11">tract </span>
   <span class="font11">(Fig. </span>
   <span class="font11">(ICHD-II) </span>
   <span class="font11">Classification </span>
   <span class="font11">Dafan </span>
   <span class="font11">Hershey </span>
   <span class="font11">Lewis </span>
   <span class="font11">Neurology </span>
   <span class="font11">Pediatr </span>
   <span class="font11">P = .) </span>
   <span class="font11">Yijing </span>
   <span class="font11">Z = ., </span>
   <span class="font11">associated </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">did </span>
   <span class="font11">effect </span>
   <span class="font11">evidence </span>
   <span class="font11">experiencing </span>
   <span class="font11">following </span>
   <span class="font11">groups </span>
   <span class="font11">headaches </span>
   <span class="font11">heterogeneity </span>
   <span class="font11">numbers </span>
   <span class="font11">n = , </span>
   <span class="font11">overall </span>
   <span class="font11">paresthesia, </span>
   <span class="font11">placebo-controlled </span>
   <span class="font11">plot </span>
   <span class="font11">quality </span>
   <span class="font11">research </span>
   <span class="font11">results </span>
   <span class="font11">scores </span>
   <span class="font11">shown </span>
   <span class="font11">shows </span>
   <span class="font11">solid; </span>
   <span class="font11">statistically </span>
   <span class="font11">trials. </span>
   <span class="font11">upper </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">.:. </span>
   <span class="font11">Analysis </span>
   <span class="font11">Clin </span>
   <span class="font11">Diener </span>
   <span class="font11">Disorders, </span>
   <span class="font11">Edition </span>
   <span class="font11">Forest </span>
   <span class="font11">Guo </span>
   <span class="font11">Int </span>
   <span class="font11">Kai </span>
   <span class="font11">Migraine </span>
   <span class="font11">Neurol </span>
   <span class="font11">Society </span>
   <span class="font11">Studies </span>
   <span class="font11">Wang </span>
   <span class="font11">anorexia, </span>
   <span class="font11">antiepileptic </span>
   <span class="font11">articles </span>
   <span class="font11">bold </span>
   <span class="font11">case </span>
   <span class="font11">change </span>
   <span class="font11">collected </span>
   <span class="font11">compared </span>
   <span class="font11">courier; </span>
   <span class="font11">decrease </span>
   <span class="font11">difference </span>
   <span class="font11">differences </span>
   <span class="font11">different </span>
   <span class="font11">disability </span>
   <span class="font11">dose </span>
   <span class="font11">double-blind, </span>
   <span class="font11">drug </span>
   <span class="font11">drugs </span>
   <span class="font11">em; </span>
   <span class="font11">extraction </span>
   <span class="font11">fatigue, </span>
   <span class="font11">follow-up </span>
   <span class="font11">group, </span>
   <span class="font11">group. </span>
   <span class="font11">higher </span>
   <span class="font11">including </span>
   <span class="font11">indicate </span>
   <span class="font11">medication </span>
   <span class="font11">model. </span>
   <span class="font11">patients. </span>
   <span class="font11">possible </span>
   <span class="font11">presented </span>
   <span class="font11">pt;} </span>
   <span class="font11">published </span>
   <span class="font11">random-effects </span>
   <span class="font11">rate </span>
   <span class="font11">result </span>
   <span class="font11">risk </span>
   <span class="font11">secondary </span>
   <span class="font11">showed </span>
   <span class="font11">total </span>
   <span class="font11">weight </span>
  </p>
 </body>
</html>
